Czy za skandale dopingowe w UE będą płacić sponsorzy? Doping ryzykiem reputacyjnym i presją dla organizacji finansujących sport i instytucji regulacyjnych
Okładka czasopisma Kultura-Społeczeństwo-Edukacja, tom 28, nr 2, rok 2025, tytuł Kultura Społeczeństwo Edukacja
PDF

Słowa kluczowe

doping
ani-doping politics
reputational risk in sport
politics on sport
sport

Jak cytować

Pepłowska, A. (2025). Czy za skandale dopingowe w UE będą płacić sponsorzy? Doping ryzykiem reputacyjnym i presją dla organizacji finansujących sport i instytucji regulacyjnych. Kultura-Społeczeństwo-Edukacja, 28(2), 279–293. https://doi.org/10.14746/kse.2025.28.2.16

Abstrakt

Operating at the intersection of competition, business and political issues, contemporary sport faces challenges from the growing expectations of sponsors and an increasingly demanding public – either spectators or voters. This article aims to demonstrate that, with the development of EU sustainability reporting regulations, sports sponsors will be required to integrate reputational risks associated with doping into their management strategies. The first section explores the impact of EU regulations, in particular the Corporate Sustainability Reporting Directive (CSRD) and the European Sustainability Reporting Standards (ESRS), on the obligations of sports sponsors and their perception of the reputational risks associated with doping. Through the example of incidents such as the suspension of Iga Świątek in 2024, it demonstrates the increasing pressure on sponsors and sports organisations to implement more effective anti-doping mechanisms. Following this, a study of reputational risk in sport is conducted, highlighting its importance in ESG management strategies and its impact on corporate investment and communication decisions. Subsequently, a discussion of the ineffectiveness of existing anti-doping policies and inequalities in enforcement around the world follows, highlighting the need for international institutions to harmonise their actions. The article is theoretical and review-based. The analysis of documents is conducted chronologically and by issue, which organises scattered threads and allows regulatory gaps to be identified. The research gap in the literature regarding sponsors’ perspectives on doping scandals provides a basis for new reflections on the role of business in contemporary sport and its social responsibility.

https://doi.org/10.14746/kse.2025.28.2.16
PDF

Bibliografia

Argenti, P., Druckenmiller, B. (2004). Reputation and the corporate brand. Corporate Reputation Review, 6(4), 368–374. DOI: https://doi.org/10.1057/palgrave.crr.1540005

Asante-Appiah, B., Lambert, T.A. (2022). The role of the external auditor in managing environmental, social, and governance (ESG) reputation risk. Review of Accounting Studies, 28, 2589–2641. DOI: https://doi.org/10.1007/s11142-022-09706-z

Bowen, G.A. (2009). Document analysis as a qualitative research method. Qualitative Research Journal, 9(2), 27–40. DOI: https://doi.org/10.3316/QRJ0902027

Carvajal, D. (2007). After scandal, cycling struggles for sponsors. The New York Times. https://www.nytimes.com/2007/05/11/business/media/11adco.html?ref=business

Chasiotis, I., Gounopoulos, D., Konstantios, D., Patsika, V. (2024). ESG reputational risk, corporate payouts and firm value. British Journal of Management, 35(2), 871–892. DOI: https://doi.org/10.1111/1467-8551.12745

Coombs, W.T. (2014). Ongoing crisis communication: Planning, managing, and responding. SAGE Publications.

Dowling, G.R. (2016). Defining and measuring corporate reputations. European Management Review, 13(3), 207–223. DOI: https://doi.org/10.1111/emre.12081

Foddy, B., Savulescu, J. (2007). Ethics of performance in sport: Drugs and gene doping. W: R.E. Ashcroft, A. Dawson, H. Draper, J.R. McMillan (red.), Principles of health care ethics (s. 511–519). John Wiley & Sons. DOI: https://doi.org/10.1002/9780470510544.ch70

Foddy, B., Savulescu, J. (2014). Using steroids ethically. W: D.E. Newton (red.), Steroids and doping in sport: A reference handbook (pp. 122–124). Bloomsbury Publishing.

Havernik, P. (2013). On the specific regulation on doping in sport. The Lawyer Quarterly, 3(1), 43–54.

Henry, I., Ko, L.-M. (2014). Routledge handbook of sport policy. Routledge. DOI: https://doi.org/10.4324/9780203807217

Houlihan, B., Green, M. (2008). Comparative elite sport development: Systems, structures and public policy. Butterworth-Heinemann. DOI: https://doi.org/10.4324/9780080554426

Konwencja Antydopingowa sporządzona w Strasburgu dnia 16 listopada 1989 r. Dz.U. 2001 nr 15, poz. 149 (2001) (Rada Europy).

Kończak, J. (2018). Polski sport 2018. Sponsoring sportowy. Fundacja Promocji i Roz-woju Sportu „Sport-Life”.

Kończak, J. (2019). Ewolucja i trendy w sponsoringu sportowym. W: D. Mańkowski, W. Woźniak (red.), Sport w ponowoczesności. Konteksty, perspektywy badawcze, narracje (s. 162–174). Wydawnictwo w Podwórku.

Lerner, A.P. (1972). The economics and politics of consumer sovereignty. American Economic Review, 62(2), 258–266.Międzynarodowa Konwencja o zwalczaniu dopingu w sporcie, sporządzona w Paryżu dnia 19 października 2005 r. Dz.U. 2007 nr 142, poz. 999 (2007) (UNESCO).

Naughton, M., Salmon, P.M., Kerhervé, H.A., McLean, S. (2025). Applying a systems thinking lens to anti-doping: A systematic review identifying the contributory factors to doping in sport. Journal of Sports Sciences, 43(1), 8–22. DOI: https://doi.org/10.1080/02640414.2024.2306056

Polski Związek Piłki Nożnej. (2023). Łączy nas więcej niż piłka. Strategia zrównoważonego rozwoju piłki nożnej w Polsce na lata 2023–2027. https://www.pzpn.pl/public/files/strategia%20zrownowazonego%20rozwoju_2023_2027.pdf

Savulescu, J. (2015). Healthy doping. W: V. Møller, I. Waddington, J. Hoberman (red.), Routledge handbook of drugs and sport (s. 350–362). Routledge. DOI: https://doi.org/10.4324/9780203795347-29

Savulescu, J., Creaney, L., Vondy, A. (2013). Should athletes be allowed to use performance enhancing drugs? British Medical Journal, 347, f6150. DOI: https://doi.org/10.1136/bmj.f6150

Savulescu, J., Foddy, B. (2011). Le tour and failure of zero tolerance: Time to relax doping controls. W: J. Savulescu, R. ter Meulen, G. Kahane (red.), Enhancing human capacities (s. 304–312). Blackwell. DOI: https://doi.org/10.1002/9781444393552.ch22

Savulescu, J., Foddy, B., Clayton, M. (2004). Why we should allow performance enhancing drugs in sport. British Journal of Sports Medicine, 38(6), 666–670.

Savulescu, J., Foddy, B., Clayton, M. (2005). Waarom we prestatieverbeterende middelen in sport zouden moeten toestaan? Geneeskunde en Sport, 38, 666–670. DOI: https://doi.org/10.1136/bjsm.2003.005249

Skup, K. (2017). Walka z dopingiem w prawie międzynarodowym i Unii Europejskiej. W: D. Kronobis-Romanowska (red.), Aktualne problemy prawa Unii Europejskiej i prawa międzynarodowego – aspekty teoretyczne i praktyczne (s. 289–352). Uniwersytet Wrocławski.

Światowa Agencja Antydopingowa. (2021). Światowy Kodeks Antydopingowy z 2021 roku, wersja polska. https://antydoping.pl/wp-content/uploads/2020/12/Swiatowy-Kodeks-Antydopingowy-2021-wersja-PL.pdf

Ustawa z dnia 21 kwietnia 2017 r. o zwalczaniu dopingu w sporcie Dz.U. 2017 poz. 1051 (2017) (Polska).

Wagner, U., Iversen, K.R. (2022). Is doping really a problem? How sponsors make sense of a sport with a dubious image. Qualitative Research in Sport, Exercise and Health, 14(7), 1082–1097. DOI: https://doi.org/10.1080/2159676X.2022.2037697